UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)

Breast cancer research : BCR, 2019-01, Vol.21 (1), p.7-7, Article 7

2019

Volltextzugriff (PDF)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study

Breast cancer research : BCR, 2021-05, Vol.23 (1), p.61-61, Article 61

2021

Volltextzugriff (PDF)

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

Proceedings of the National Academy of Sciences - PNAS, 2017-10, Vol.114 (44), p.E9346-E9355

2017

Volltextzugriff (PDF)

Translesion Synthesis or Repair by Specialized DNA Polymerases Limits Excessive Genomic Instability upon Replication Stress

International journal of molecular sciences, 2021-04, Vol.22 (8), p.3924

2021

Volltextzugriff (PDF)

Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer

Cancers, 2021-08, Vol.13 (16), p.4132

2021

Volltextzugriff (PDF)

Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer

Scientific reports, 2019-05, Vol.9 (1), p.7715-7715, Article 7715

2019

Volltextzugriff (PDF)

Bifascicular nature of the flexor digitorum profundus and flexor pollicis longus tendons: forgotten anatomical characteristics rediscovered with US imaging

European radiology, 2020-12, Vol.30 (12), p.6653-6662

2020

Volltextzugriff (PDF)

Histoséminaire : ouf, c’est positif ! De l’usage salvateur des biomarqueurs en pathologie mammaire : cas no 5

Annales de pathologie, 2022-07, Vol.42 (4), p.313-316

Franchet, Camille

2022

Volltextzugriff (PDF)

Histoséminaire : Ouf, c’est positif ! De l’usage salvateur des biomarqueurs en pathologie mammaire : cas n°7

Annales de pathologie, 2022-07, Vol.42 (4), p.325-328

Franchet, Camille

2022

Volltextzugriff (PDF)

Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case no 5

Annales de pathologie, 2022-07, Vol.42 (4), p.313-316

Franchet, Camille

2022

Volltextzugriff (PDF)

Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case n°7

Annales de pathologie, 2022-07, Vol.42 (4), p.325-328

Franchet, Camille

2022

Volltextzugriff (PDF)

Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer

Cancers, 2021-08, Vol.13 (16), p.4059

2021

Volltextzugriff (PDF)

Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining

Cancers, 2018-10, Vol.10 (11), p.415

2018

Volltextzugriff (PDF)

Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability

Frontiers in cell and developmental biology, 2021-08, Vol.9, p.727429-727429

2021

Volltextzugriff (PDF)

Ouf, c’est positif ! – De l’usage des biomarqueurs en pathologie mammaire. Pré-test

Annales de pathologie, 2022-07, Vol.42 (4), p.286-288

2022

Volltextzugriff (PDF)

Ouf, c’est positif ! – De l’usage des biomarqueurs en pathologie mammaire. Réponses au pré-test

Annales de pathologie, 2022-07, Vol.42 (4), p.289-290

2022

Volltextzugriff (PDF)

PARPi, immunothérapies et anticorps monoclonaux conjugués dans les cancers du sein triple-négatifs

Bulletin du cancer, 2021-01, Vol.108 (1), p.67-79

2021

Volltextzugriff (PDF)

Cancer du sein luminal et apport des classifications intrinsèques moléculaires : comment identifier les tumeurs luminales A et B en 2015 ?

Bulletin du cancer, 2015-06, Vol.102 (6), p.S34-S46

2015

Volltextzugriff (PDF)

When RAD52 Allows Mitosis to Accept Unscheduled DNA Synthesis

Cancers, 2019-12, Vol.12 (1), p.26

2019

Volltextzugriff (PDF)

EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (6), p.1595-1606

2021

Volltextzugriff (PDF)

Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis

Cell death & disease, 2019-12, Vol.10 (12), p.956-12, Article 956

2019

Volltextzugriff (PDF)

Several immune escape patterns in non-Hodgkin's lymphomas

Oncoimmunology, 2015-08, Vol.4 (8), p.e1026530-e1026530

2015

Volltextzugriff (PDF)

Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates

Bulletin du cancer, 2021-01, Vol.108 (1), p.67

2021

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

Translesion Synthesis or Repair by Specialized DNA Polymerases Limits Excessive Genomic Instability upon Replication Stress

Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer

Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer

Bifascicular nature of the flexor digitorum profundus and flexor pollicis longus tendons: forgotten anatomical characteristics rediscovered with US imaging

Histoséminaire : ouf, c’est positif ! De l’usage salvateur des biomarqueurs en pathologie mammaire : cas no 5

Histoséminaire : Ouf, c’est positif ! De l’usage salvateur des biomarqueurs en pathologie mammaire : cas n°7

Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case no 5

Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case n°7

Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer

Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining

Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability

Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer

Ouf, c’est positif ! – De l’usage des biomarqueurs en pathologie mammaire. Pré-test

Ouf, c’est positif ! – De l’usage des biomarqueurs en pathologie mammaire. Réponses au pré-test

PARPi, immunothérapies et anticorps monoclonaux conjugués dans les cancers du sein triple-négatifs

Cancer du sein luminal et apport des classifications intrinsèques moléculaires : comment identifier les tumeurs luminales A et B en 2015 ?

When RAD52 Allows Mitosis to Accept Unscheduled DNA Synthesis

EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers

Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis

Several immune escape patterns in non-Hodgkin's lymphomas

Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates

Suchergebnisse filtern